This post was originally published on this site
Of course, low-priced stocks can fall just as quickly as they can rise. Therefore, I don’t recommend taking a huge position in PharmaCyte shares.
That being said, a moderate stake in PMCB stock could yield sizable returns. Plus, you can feel good about investing in PharmaCyte Biotech as the company battles against life-threatening diseases.
